stoxline Quote Chart Rank Option Currency Glossary
  
Silo Pharma, Inc. (SILO)
2  0.09 (4.71%)    05-30 16:00
Open: 1.975
High: 2.0584
Volume: 70,552
  
Pre. Close: 1.91
Low: 1.871
Market Cap: 6(M)
Technical analysis
2024-05-30 4:44:26 PM
Short term     
Mid term     
Targets 6-month :  2.45 1-year :  2.76
Resists First :  2.1 Second :  2.36
Pivot price 1.93
Supports First :  1.66 Second :  1.38
MAs MA(5) :  1.95 MA(20) :  1.89
MA(100) :  1.73 MA(250) :  1.77
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  41.4 D(3) :  40
RSI RSI(14): 53.7
52-week High :  3.04 Low :  1.21
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ SILO ] has closed below upper band by 39.7%. Bollinger Bands are 112.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.06 - 2.07 2.07 - 2.09
Low: 1.89 - 1.91 1.91 - 1.92
Close: 1.98 - 2 2 - 2.02
Company Description

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.

Headline News

Thu, 30 May 2024
Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Decreases By 26.4% - Defense World

Wed, 22 May 2024
Silo Pharma (NASDAQ:SILO) Trading Up 7.4% - Defense World

Tue, 21 May 2024
Silo Pharma reports progress in depression treatment study - Investing.com

Tue, 21 May 2024
Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention - Yahoo Finance

Tue, 14 May 2024
Silo Pharma to discuss ketamine treatments at FDA event - Investing.com

Wed, 27 Mar 2024
Silo Pharma Full Year 2023 Earnings: EPS Misses Expectations - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
PNK
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 3 (M)
Held by Insiders 2.54e+006 (%)
Held by Institutions 6.3 (%)
Shares Short 61 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -5 %
Return on Assets (ttm) 347.4 %
Return on Equity (ttm) -24.9 %
Qtrly Rev. Growth 72100 %
Gross Profit (p.s.) 0
Sales Per Share -32.82
EBITDA (p.s.) 0
Qtrly Earnings Growth -1.2 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -3 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales -0.07
Price to Cash Flow 1.26
Stock Dividends
Dividend 0
Forward Dividend 145580
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android